中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
BLT1 in dendritic cells promotes Th1/Th17 differentiation and its deficiency ameliorates TNBS-induced colitis

文献类型:期刊论文

作者Zhou, Jinfeng2; Lai, Weiming2; Yang, Wanjie2; Pan, Juping1; Shen, Hu1; Cai, Yingying2; Yang, Cuixia2; Ma, Ningjia2; Zhang, Yue2; Zhang, Ru2
刊名CELLULAR & MOLECULAR IMMUNOLOGY
出版日期2018-12
卷号15期号:12页码:1047-1056
ISSN号1672-7681
DOI10.1038/s41423-018-0030-2
文献子类Article
英文摘要Leukotriene B4 (LTB4) synthesis is enhanced in the colonic mucosa in patients with inflammatory bowel disease (IBD). BLT1, a high-affinity receptor for LTB4, exhibits no effect on the progression of dextran sodium sulfate (DSS)-induced colitis, which mostly relies on innate immunity. Here, we reported that BLT1 regulates trinitrobenzene sulfonic add (TNBS)-induced colitis, which reflects CD4(+) T-cell-dependent adaptive immune mechanisms of IBD. We found that BLT1 signaling enhanced the progression of colitis through controlling the production of proinflammatory cytokines by dendritic cells (DCs) and modulating the differentiation of Th1 and Th17. BLT1(-/-) mice displayed an alleviated severity of TNBS-induced colitis with reduced body weight loss and infiltrating cells in the lamina propria. BLT1 deficiency in DCs led to reduced production of proinflammatory cytokines, including IL-6, TNF-alpha, and IL-12, and these results were further confirmed via treatment with a BLT1 antagonist. The impaired cytokine production by BLT1(-/-) DCs subsequently led to reduced Th1 and Th17 differentiation both in vitro and in vivo. We further performed a conditional DC reconstitution experiment to assess whether BLT1 in DCs plays a major role in regulating the pathogenesis of TNBS-induced colitis, and the results indicate that BLT1 deficiency in DCs also significantly reduces disease severity. The mechanistic study demonstrated that BLT1-regulated proinflammatory cytokine production through the Gai beta gamma subunit-phospholipase C beta (PLC beta)-PKC pathway. Notably, we found that treatment with the BLT1 antagonist also reduced the production of proinflammatory cytokines by human peripheral blood DCs. Our findings reveal the critical role of BLT1 in regulating adaptive immunity and TNBS-induced colitis, which further supports BLT1 as a potential drug target for adaptive immunity-mediated IBD.
WOS关键词LEUKOTRIENE B-4 RECEPTOR ; INTESTINAL INFLAMMATION ; MOUSE MODEL ; TH17 CELLS ; ACTIVATION ; EXPRESSION ; PATHOGENESIS ; REQUIREMENT ; ANTAGONIST ; MECHANISMS
资助项目Ministry of Science and Technology of China[2014CB541903] ; National Natural Science Foundation of China[31171348] ; National Natural Science Foundation of China[31371414] ; Fundamental Research Funds for the Central Universities[00000000]
WOS研究方向Immunology
语种英语
出版者CHIN SOCIETY IMMUNOLOGY
WOS记录号WOS:000451835100005
源URL[http://119.78.100.183/handle/2S10ELR8/279479]  
专题国家新药筛选中心
通讯作者Gao, Yuan; Du, Changsheng
作者单位1.Tongji Univ, Tongji Hosp, Tongji Univ branch, Shanghai 200092, Peoples R China;
2.Tongji Univ, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Putuo Dist Peoples Hosp, Shanghai 200092, Peoples R China;
3.Tsinghua Univ, Inst Immunol, Beijing 100086, Peoples R China;
4.Tsinghua Univ, Sch Med, Beijing 100086, Peoples R China
5.Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China;
推荐引用方式
GB/T 7714
Zhou, Jinfeng,Lai, Weiming,Yang, Wanjie,et al. BLT1 in dendritic cells promotes Th1/Th17 differentiation and its deficiency ameliorates TNBS-induced colitis[J]. CELLULAR & MOLECULAR IMMUNOLOGY,2018,15(12):1047-1056.
APA Zhou, Jinfeng.,Lai, Weiming.,Yang, Wanjie.,Pan, Juping.,Shen, Hu.,...&Du, Changsheng.(2018).BLT1 in dendritic cells promotes Th1/Th17 differentiation and its deficiency ameliorates TNBS-induced colitis.CELLULAR & MOLECULAR IMMUNOLOGY,15(12),1047-1056.
MLA Zhou, Jinfeng,et al."BLT1 in dendritic cells promotes Th1/Th17 differentiation and its deficiency ameliorates TNBS-induced colitis".CELLULAR & MOLECULAR IMMUNOLOGY 15.12(2018):1047-1056.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。